Wexford Capital’s GoodRx Holdings GDRX Stock Holding History

Wexford Capital’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-40,606	Closed	-$1.64M	–	258
2020 Q4	$1.64M	Buy	+40,606	New	+$1.87M	0.26%	85

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ZCI

Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return

Wexford Capital's GDRX Position: Q1 2021 in Review

Wexford Capital sold out of GoodRx Holdings (GDRX) in Q1 2021, closing a stake of 40,606 shares — an estimated $1.64M sold.

Wexford Capital first reported a position in GDRX in Q4 2020 and held it in 1 quarter. The position peaked at $1.64M in Q4 2020. 205 funds tracked by Wall St. Rank hold GDRX as of Q1 2021.

Wexford Capital reported no remaining GoodRx Holdings position as of Q1 2021 after selling out during the quarter.
Wexford Capital sold 40,606 GoodRx Holdings shares in Q1 2021, an estimated $1.64M.
Wexford Capital first reported a position in GoodRx Holdings in Q4 2020 and held it in 1 quarter.
Wexford Capital's GoodRx Holdings position peaked at $1.64M in Q4 2020.
205 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2021.

Based on Wexford Capital's 13F filing for Q1 2021, filed 13 May 2021.